{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:22:43Z","timestamp":1777602163228,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clineuro.2023.107962","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T14:08:22Z","timestamp":1694009302000},"page":"107962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Risk factors of hyperammonemia in epilepsy patients with valproic acid therapy"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4965-4737","authenticated-orcid":false,"given":"Dong Won","family":"Kwack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4484-0602","authenticated-orcid":false,"given":"Dong Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1A","key":"10.1016\/j.clineuro.2023.107962_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0002-9343(88)90055-1","article-title":"Side effects of valproate","volume":"84","author":"Dreifuss","year":"1988","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.clineuro.2023.107962_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.9740\/mhc.2018.03.073","article-title":"Valproic acid-induced hyperammonemia: Incidence, clinical significance, and treatment management","volume":"8","author":"Baddour","year":"2018","journal-title":"Ment. Health Clin."},{"issue":"2","key":"10.1016\/j.clineuro.2023.107962_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s00467-011-1838-5","article-title":"Hyperammonemia in review: pathophysiology, diagnosis, and treatment","volume":"27","author":"Auron","year":"2012","journal-title":"Pedia Nephrol."},{"issue":"11","key":"10.1016\/j.clineuro.2023.107962_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000066","article-title":"Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy","volume":"93","author":"Tseng","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clineuro.2023.107962_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.578922","article-title":"Disturbance of the glutamate-glutamine cycle, secondary to hepatic damage, compromises memory function","volume":"15","author":"Limon","year":"2021","journal-title":"Front Neurosci."},{"issue":"3","key":"10.1016\/j.clineuro.2023.107962_bib6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00005792-200205000-00007","article-title":"Hyperammonemic encephalopathy","volume":"81","author":"Brusilow","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.clineuro.2023.107962_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1528-1167.2012.03532.x","article-title":"Topiramate increases the risk of valproic acid-induced encephalopathy","volume":"54","author":"Noh","year":"2013","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.clineuro.2023.107962_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/epi.12125","article-title":"Risk factors for hyperammonemia in pediatric patients with epilepsy","volume":"54","author":"Yamamoto","year":"2013","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.clineuro.2023.107962_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2008.06.006","article-title":"Lamotrigine might potentiate valproic acid-induced hyperammonemic encephalopathy","volume":"32","author":"Fan","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.clineuro.2023.107962_bib10","unstructured":"W.C.C.f.D.S. Methodology, Guidelines for ATC classification and DDD assignment, (2022)."},{"issue":"8","key":"10.1016\/j.clineuro.2023.107962_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136220","article-title":"Hyperammonemia in urinary tract infections","volume":"10","author":"Kenzaka","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clineuro.2023.107962_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00655.x","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"114","author":"Segura-Bruna","year":"2006","journal-title":"Acta Neurol. Scand."},{"issue":"3","key":"10.1016\/j.clineuro.2023.107962_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10030187","article-title":"Valproic acid-induced hyperammonemic encephalopathy in a patient with bipolar disorder: a case report","volume":"10","author":"Wu","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.clineuro.2023.107962_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106697","article-title":"Factors associated with blood carnitine levels in adult epilepsy patients with chronic valproic acid therapy","volume":"175","author":"Saito","year":"2021","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.clineuro.2023.107962_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.107967","article-title":"Valproic acid-induced encephalopathy: a review of clinical features, risk factors, diagnosis, and treatment","volume":"120","author":"Wu","year":"2021","journal-title":"Epilepsy Behav."},{"issue":"2","key":"10.1016\/j.clineuro.2023.107962_bib16","doi-asserted-by":"crossref","DOI":"10.5214\/ans.0972.7531.210210","article-title":"Non-hyperammonemic valproate encephalopathy","volume":"21","author":"Farooq","year":"2014","journal-title":"Ann. Neurosci."},{"issue":"26","key":"10.1016\/j.clineuro.2023.107962_bib17","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029780","article-title":"Risk factors of elevated blood ammonia level in epilepsy patients treated with lamotrigine","volume":"101","author":"Chen","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.clineuro.2023.107962_bib18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.14581\/jer.14017","article-title":"Valproic acid-induced hyperammonemic encephalopathy promoted by levetiracetam","volume":"4","author":"Roh","year":"2014","journal-title":"J. Epilepsy Res."},{"issue":"4","key":"10.1016\/j.clineuro.2023.107962_bib19","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharm. Genom."},{"issue":"3","key":"10.1016\/j.clineuro.2023.107962_bib20","doi-asserted-by":"crossref","DOI":"10.1592\/phco.26.3.375","article-title":"Topiramate for migraine prevention","volume":"26","author":"Wenzel","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.clineuro.2023.107962_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/8755122515605849","article-title":"Topiramate-related hyperammonemia","volume":"32","author":"Moore","year":"2016","journal-title":"J. Pharm. Technol."},{"issue":"8","key":"10.1016\/j.clineuro.2023.107962_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/08860220802272613","article-title":"Valproate-induced hyperammonemic encephalopathy treated by hemodialysis","volume":"30","author":"Tsai","year":"2008","journal-title":"Ren. Fail"},{"key":"10.1016\/j.clineuro.2023.107962_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/bs.acc.2015.12.001","article-title":"Inborn errors of metabolism","volume":"73","author":"Ezgu","year":"2016","journal-title":"Adv. Clin. Chem."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846723003785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846723003785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T14:29:21Z","timestamp":1749220161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846723003785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":23,"alternative-id":["S0303846723003785"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2023.107962","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors of hyperammonemia in epilepsy patients with valproic acid therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2023.107962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107962"}}